Amarin Corporation operates under the executive leadership of Aaron Berg, who serves as the President and Chief Executive Officer. Appointed to the role to steer the company through its commercial expansion and strategic transformation phases, he brings extensive executive pharmaceutical experience. Working alongside an experienced management team and board of directors, he oversees global operations, commercialization strategies for Vascepa, and research and development initiatives designed to improve cardiovascular health outcomes for patients worldwide.